Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Recurrent × Nelfinavir × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Genitourinary 1

Conditions

Prostate Cancer Recurrent 1 Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

tempol 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 TEMPOL-H 1 Sirolimus 1 Nelfinavir 1 Metformin 1 Hydroxychloroquine 1 Diet, Protein-Restricted 1 Dasatinib 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05036226 2025-10-06

COAST

Medical University of South Carolina

Phase 1/2 Recruiting

GenitourinaryOther solid neoplasm

Prostate Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡